C-Myc then promotes lactate-dependent expression of serine/arginine-rich splicing factor 10 (SRSF10), which induces alternative splicing of genes such as the apoptosis inhibitor, Bcl-x, and enhances tumour survival (Pandkar et al., 2023). This evidence concerns the gene SRSF10 and neoplasm.